ArticleBMC bioinformatics2025
GNNs and ensemble models enhance the prediction of new sRNA-mRNA interactions in unseen conditions.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Bacterial small RNAs (sRNAs) are pivotal in post-transcriptional regulation, affecting functions like virulence, metabolism, and gene expression by binding specific mRNA targets. Identifying these targets is crucial to understanding sRNA regulation across species. Despite advancements in high-throughput (HT) experimental methods, they remain technically challenging and are limited to detecting sRNA-target interactions under specific environmental conditions. Therefore, computational approaches, especially machine learning (ML), are essential for identifying strong candidates for biological validation. In this paper, we hypothesize that ML models trained on large-scale interaction data from specific conditions can accurately predict new interactions in unseen conditions within the same bacterial strain. To test this, we developed models from two families: (1) graph neural networks (GNNs), including GraphRNA and kGraphRNA, that learn transformed representations of interacting sRNA-mRNA pairs via graph relationships, and (2) decision forests, sInterRF (Random Forest) and sInterXGB (XGBoost), which use various interaction features for prediction. We also proposed Summation Ensemble Models (SEM) that combine scores from multiple models. Across three seen-to-unseen conditions evaluations, our models -particularly kGraphRNA- significantly improved the area under the ROC curve (AUC) and Precision-Recall curve (PR-AUC) compared to sRNARFTarget, CopraRNA, and RNAup. The SEM model combining GraphRNA and CopraRNA outperformed CopraRNA alone on a low-throughput (LT) interactions test set (HT-to-LT evaluation). Beyond enhanced performance, our models enable target prediction for species-specific sRNAs, a capability lacking in some existing tools. Furthermore, GNN models remove the dependency on external tools like RNAplex or RNAup to compute hybridization duplex or energy features, enhancing scalability and runtime efficiency. While this study focuses on E. coli K12 MG1655 interactions, our methods are fully adaptable to predict interactions in other bacterial strains, given sufficient data for training. Our comprehensive feature importance analysis revealed the complexity of sRNA-mRNA interactions across environmental conditions, underscoring the significance of RNA sequence composition and duplex structure characteristics, like base pairing and energy factors; findings that align with biological evidence from previous studies. As HT experiments expand sRNA-target interaction data across conditions in various bacteria, our ML methods with features analysis offer promising advances in sRNA-target prediction and deeper insights into sRNA regulatory mechanisms across diverse species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.